Samsung Securities Reports Change in Stake in Gukjeon Pharmaceutical (Simple Investment Purpose)
Samsung Securities and its special relations (including Samsung-Rynos Mezzanine New Technology Business Investment Fund No.1, etc.) report a change in holdings of Gukjeon Pharmaceutical shares.
The purpose is simple investment, not affecting management rights.
Shares held based on reporting entity's contribution ratio: JB-Rynos 1,896 shares, Samsung-Rynos 2,403 shares, total 4,299 shares (as of Dec 31, 2025).
Filed as a simplified report by a professional investor eligible for reporting exemption; no special relationship with the company's largest shareholder.